Mode
Text Size
Log in / Sign up
N/A N=32 Randomized Treatment

Semi-Recumbent Vibration Therapy in Older Adults

Sarcopenia · Aging

Enrolled (actual)
32
Serious AEs
9.4%
Results posted
Apr 2019
Primary outcome: Primary: Weight Corrected Jump Power Based on Participant's Jump on the Jump Force Plate — 10.53; 10.28; 11.10; 8.98 W/kg — p=0.217

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
VibeTech One (Device)
Age
Older Adult · 70+ yrs
Sex
All
Sponsor
University of Wisconsin, Madison
Primary completion
Feb 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Weight Corrected Jump Power Based on Participant's Jump on the Jump Force Plate
10.53; 10.28; 11.10; 8.98 0.217
SECONDARY
Grip Strength
13.8; 12.9; 13.3; 14.1 0.501
SECONDARY
Gait Speed
0.6; 0.7; 0.7; 0.7 0.151
SECONDARY
Sway
9.2; 4.8; 5.8; 4.7 0.450
SECONDARY
Short Physical Performance Battery (SPPB)
6.8; 7.0; 6.8; 7.0 0.678
SECONDARY
Timed-Up-and-Go (TUG)
18.6; 18.4; 20.5; 19.3 0.060
SECONDARY
Bioelectrical Impedance Spectroscopy (BIS)
41.75; 41.86; 42.19; 41.71 0.483

Summary

This proposed prospective study will evaluate whether a novel exercise approach, seated vibration therapy, can improve function in the target population of older adults. Therefore, the primary aim of this pilot is to examine the effect of vibration therapy on muscle function (balance, muscle power and strength) and muscle mass.

Eligibility Criteria

Inclusion Criteria

  • Men and women age ≥ 70 years
  • Able and willing to sign informed consent
  • Able to stand without assistance
  • Able and willing to train for 10 minutes, 3 times per week
  • Total SPPB score of ≤ 9 or ≤ 2 in any of the three tests included in the SPPB

Exclusion Criteria

  • Cognitive impairment to the degree that it limits the ability of signing informed consent
  • Unable to sit upright for 10 minutes
  • History of injury or surgery within the prior six months which limits the ability to ambulate
  • Major illness that might cause missed training sessions or visits.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02533063). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search